Aprepitant 40 MG capsule UDS
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,756
Award facts
- Contract value 100% obligated
- $1,756.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,756.25 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This competitively awarded, firm fixed-price order, which originated under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. No set-aside designation was utilized for this award. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Aprepitant is a prescription antiemetic medication commonly used to prevent chemotherapy-induced nausea and vomiting, making this delivery order part of the Defense Logistics Agency's ongoing efforts to maintain pharmaceutical supply chain readiness for military healthcare operations. The award reflects the routine, competitive task order process under DLA's pharmaceutical prime vendor program, which leverages established indefinite delivery vehicles to efficiently procure essential medications across multiple therapeutic domains in support of military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F0ZQ3?
SPE2DR26F0ZQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F0ZQ3 worth?
The government has obligated $1,756 on SPE2DR26F0ZQ3.
Is contract SPE2DR26F0ZQ3 an order under another contract?
Yes. SPE2DR26F0ZQ3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZQ3 competed?
The extent of competition for SPE2DR26F0ZQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award